Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV6 | Q9H1D0 | 5/20 | 0.45 |
| ▸ | ORAI1 | Q96D31 | 4/20 | 0.44 |
| ▸ | ORAI2 | Q96SN7 | 4/20 | 0.44 |
| ▸ | ORAI3 | Q9BRQ5 | 4/20 | 0.44 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
| ▸ | CA5A | P35218 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 4/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28830120 | 0.79 | TRPV6 (0.40) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL2492717 | 0.78 | ENPP2 (0.48) | TRPV6ORAI1ORAI2ORAI3ENPP2 | |
| SCHEMBL28474744 | 0.78 | CA2 (0.48) | TRPV6ORAI1ORAI2ORAI3CA5A | |
| SCHEMBL874879 | 0.78 | TRPV6 (0.42) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL26452 | 0.77 | TRPV6 (0.44) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL8515033 | 0.77 | TRPV6 (0.44) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL12615910 | 0.77 | NPC1 (0.36) | MGLLALDH1A1 | |
| SCHEMBL17767360 | 0.77 | TRPV6 (0.38) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL874878 | 0.76 | TRPV6 (0.40) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL25376692 | 0.76 | TRPV6 (0.42) | TRPV6ORAI1ORAI2ORAI3PCSK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 508 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060240-A | Long-acting antistatic PE packaging film material and preparation method thereof | 广州星辰包装有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-12221435-B2 | Organic molecules, in particular for use in optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-02-11 | — | — | US | claimed |
| CN-118878402-A | Preparation method of trifluoromethyl ketone compound based on palladium catalysis of C-N bond cleavage | 大连理工大学 | 2024-11-01 | — | — | CN | claimed |
| CN-118344378-A | Beta-axis chiral porphyrin compound and preparation method thereof through Suzuki coupling reaction | 同济大学 | 2024-07-16 | — | — | CN | claimed |
| CN-118307536-A | 4, 7-Bis (3, 5-bis (trifluoromethyl) phenyl) -1, 10-phenanthroline framework ligand and synthesis method and application thereof | 浙江工业大学 | 2024-07-09 | — | — | CN | claimed |
| CN-118084682-A | Tetraphenylenediamine monomer containing trifluoromethyl and preparation method and application thereof | 株洲时代新材料科技股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117865773-A | Preparation method of difluoromethyl aromatic compound based on palladium-catalyzed decarbonylation coupling | 大连理工大学 | 2024-04-12 | — | — | CN | claimed |
| CN-113621215-B | Preparation method of organic-inorganic hybrid biomass phenolic resin ablation-resistant material | 哈尔滨工业大学 | 2024-02-09 | — | — | CN | claimed |
| CN-116981678-A | Method for synthesizing reactive carbohydrates comprising antigen precursors for conjugation to a carrier material | 科兰克斯资本 | 2023-10-31 | — | — | CN | claimed |
| CN-116916755-A | Materials and methods for extending the shelf life of food products | JP实验室公司 | 2023-10-20 | — | — | CN | claimed |
| CN-110799625-A | Organic molecules, in particular for optoelectronic devices | 辛诺拉有限公司 | 2020-02-14 | — | — | CN | claimed |
| CN-107074675-B | Preparation method of chiral 2- [ 1-cyclopropylethyl ] -6-isopropyl-phenol | 四川海思科制药有限公司 | 2019-12-20 | — | — | CN | claimed |
| CN-107108416-B | Preparation method of 1, 2-dicyclopropylethylphenol and optical isomer thereof | 四川海思科制药有限公司 | 2019-12-20 | — | — | CN | claimed |
| WO-2019053049-A1 | ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-03-21 | — | — | WO | claimed |
| WO-2015145333-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND ITS INTERMEDIATE | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2015-10-01 | — | — | WO | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| EP-1313560-A4 | CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION | UNIV YALE (US) | 2005-02-09 | — | — | EP | claimed |
| EP-1313560-A1 | CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION | YALE UNIVERSITY (US) | 2003-05-28 | — | — | EP | claimed |
| WO-2002011883-A1 | CATALYST FOR AROMATIC C-O, C-N, and C-C BOND FORMATION | YALE UNIVERSITY (US) | 2002-02-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12221435-B2 | Organic molecules, in particular for use in optoelectronic devices | OR10J3, EPCAM, OR51E2 | TRPV6 497/4885ORAI1 1759/4885ORAI2 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.